Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
4FOX Ventures
Switzerland
- Lausanne
- 17/11/2022
- Series A
- $5,000,000
4FOX Ventures is a leading Swiss healthcare and technology focused venture capital team managing a portfolio of over 10 highly innovative and fast-growing companies composed, amongst others, of:
(i) Ecorobotix (https://www.ecorobotix.com/en/);
(ii) Neomedical (https://neo-medical.com/);
(iii) Giotto Compliance (https://giotto.ai/);
(iv) Aspivix (https://www.aspivix.com/);
(v) Artiria Medical (https://artiria-medical.com/);
(vi) Positrigo (https://www.positrigo.com/);
(vii) Vima (https://vima-swiss.com/);
(viii) Faveeo (https://www.faveeo.com/);
(ix) Kairos (https://www.kairosfire.com/);
(x) Scailyte (https://scailyte.com/).
We usually invest as first institutional investor in early stage Swiss companies with potential to develop and tackle early on the booming Asian market.
Through active board representation, we deliver direct operational and industry support.
- Industry Venture Capital and Private Equity Principals
- Website http://4fox-ventures.com/
- LinkedIn https://www.linkedin.com/company/4fox-ventures/
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)